Antitumor Activity of the Combination of Bendamustine With Vorinostat in Diffuse Large B-Cell Lymphoma Cells

Clinical Lymphoma, Myeloma and Leukemia - United States
doi 10.1016/j.clml.2015.07.124
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

A Phase II Trial of Bendamustine in Combination With Rituximab in Older Patients With Previously Untreated Diffuse Large B-Cell Lymphoma

British Journal of Haematology
Hematology
2016English

Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma

Annals of Hematology
MedicineHematology
2013English

Diffuse Large B-Cell Lymphoma

2020English

Real-World Bendamustine Use in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R Dlbcl)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

mTOR Activity in AIDS-related Diffuse Large B-Cell Lymphoma

PLoS ONE
Multidisciplinary
2017English

Safety and Activity of Ibrutinib in Combination With Durvalumab in Patients With Relapsed or Refractory Follicular Lymphoma or Diffuse Large B‐cell Lymphoma

American Journal of Hematology
Hematology
2019English

B-Cell Receptor Signaling in Diffuse Large B-Cell Lymphoma

Seminars in Hematology
Hematology
2015English

The Genetic Landscape of Diffuse Large B-Cell Lymphoma

Seminars in Hematology
Hematology
2015English

Primary Diffuse Large B-Cell Lymphoma of the Mandible

Autopsy and Case Reports
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy